Global Live Cell Imaging Market 2022 - Industry Briefing
In 2021, the global live cell imaging market stood at USD 1,779 million. Recording a CAGR of 6.9% from 2022 to 2028, the worth is projected to reach ~USD 2,844 million by 2028, according to a new report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the component, application, and region. The global market data on live cell imaging can be segmented by component: equipment, consumables, software and services. The equipment segment held the largest share of the global live cell imaging market in 2021 and is anticipated to hold its share during the forecast period. Live cell imaging market is further segmented by application: cell biology, developmental biology, stem cell biology, drug discovery, others. Globally, the cell biology segment made up the largest share of the live cell imaging market. Based on region, the live cell imaging market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global live cell imaging market in 2021.
The global live cell imaging market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook